Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q3 FY2019
As of Sep 30, 2019
Q2 FY2019
As of Jun 30, 2019
Q1 FY2019
As of Mar 31, 2019
Q4 FY2018
As of Dec 31, 2018
ASSETS
Current assets:
Cash and cash equivalents
Receivables from service providers
Short-term investments
Restricted cash
Fiduciary funds - restricted
Trade accounts receivable, less allowances of $13,971 and $18,167, respectively
Other current assets
Total current assets
Property and equipment, net
Right-of-use assets
Goodwill
Intangibles, net
Indefinite-lived intangibles
Capitalized software development costs, net
Non Current Accounts receivable, less allowance
Deferred tax asset, net
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Payables to service agents
Accrued payroll and related benefits
Working capital facility
Fiduciary funds - restricted
Contingent liability for earn-out acquisition consideration
Revolving line of credit
Short-term debt
Current portion of long term debt and financing lease obligations, net of deferred financing costs of $3,287 and $469, respectively
Contract liabilities
Lease liability
Other current liabilities
Total current liabilities
Revolving line of credit
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $261, respectively
Contingent liability for earn-out acquisition consideration
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $0 and $0, respectively
Contingent liability for accrued earn-out acquisition consideration
Contract liabilities
Lease liability
Deferred tax liability, net
Other liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022
Preferred Stock
Total preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022
Series Y Convertible preferred stock
Total series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at September 30, 2023 and December 31, 2022
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,899,335 issued and outstanding, at September 30, 2023, and 30,819,533 issued and outstanding at December 31, 2022
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total Ebix, Inc. stockholders’ equity
Noncontrolling interest
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support